Wedbush Securities Inc Amarin Corp Plcuk Transaction History

Wedbush Securities Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$4.04 - $5.31 $47,126 - $61,941	-11,665 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$3.64 - $7.76 $29,120 - $62,080	-8,000 Reduced 40.68%	11,665 $49,000
Q2 2020 Jul 16, 2020	BUY	$4.78 - $8.26 $43,020 - $74,340	9,000 Added 84.39%	19,665 $136,000
Q1 2020 Apr 17, 2020	BUY	$4.0 - $21.53 $2,000 - $10,765	500 Added 4.92%	10,665 $43,000
Q4 2019 Jan 16, 2020	SELL	$13.94 - $24.12 $4,669 - $8,080	-335 Reduced 3.19%	10,165 $218,000
Q3 2019 Oct 17, 2019	BUY	$13.89 - $23.16 $145,845 - $243,180	10,500 New	10,500 $159,000

183

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.